HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Metabolic syndrome impairs notch signaling and promotes apoptosis in chronically ischemic myocardium.

AbstractOBJECTIVE:
Impaired angiogenesis is a known consequence of metabolic syndrome (MetS); however, the mechanism is not fully understood. Recent studies have shown that the notch signaling pathway is an integral component of cardiac angiogenesis. We tested, in a clinically relevant swine model, the effects of MetS on notch and apoptosis signaling in chronically ischemic myocardium.
METHODS:
Ossabaw swine were fed either a regular diet (control [CTL], n = 8) or a high-cholesterol diet (MetS, n = 8) to induce MetS. An ameroid constrictor was placed to induce chronic myocardial ischemia. Eleven weeks later, the wine underwent cardiac harvest of the ischemic myocardium.
RESULTS:
Downregulation of pro-angiogenesis proteins notch2, notch4, jagged2, angiopoietin 1, and endothelial nitric oxide synthase were found in the MetS group compared with the CTL group. Also, upregulation of pro-apoptosis protein caspase 8 and downregulation of anti-angiogenesis protein phosphorylated forkhead box transcription factor 03 and pro-survival proteins phosphorylated P38 and heat shock protein 90 were present in the MetS group. Cell death was increased in the MetS group compared with the CTL group. Both CTL and MetS groups had a similar arteriolar count and capillary density, and notch3 and jagged1 were both similarly concentrated in the smooth muscle wall.
CONCLUSIONS:
MetS in chronic myocardial ischemia significantly impairs notch signaling by downregulating notch receptors, ligands, and pro-angiogenesis proteins. MetS also increases apoptosis signaling, decreases survival signaling, and increases cell death in chronically ischemic myocardium. Although short-term angiogenesis appears unaffected in this model of early MetS, the molecular signals for angiogenesis are impaired, suggesting that inhibition of notch signaling might underlie the decreased angiogenesis in later stages of MetS.
AuthorsNassrene Y Elmadhun, Ashraf A Sabe, Antonio D Lassaletta, Louis M Chu, Katelyn Kondra, Michael Sturek, Frank W Sellke
JournalThe Journal of thoracic and cardiovascular surgery (J Thorac Cardiovasc Surg) Vol. 148 Issue 3 Pg. 1048-55; discussion 1055 (Sep 2014) ISSN: 1097-685X [Electronic] United States
PMID25037620 (Publication Type: Journal Article)
CopyrightCopyright © 2014 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.
Chemical References
  • Angiogenic Proteins
  • Apoptosis Regulatory Proteins
  • Receptors, Notch
Topics
  • Angiogenic Proteins (metabolism)
  • Animals
  • Apoptosis
  • Apoptosis Regulatory Proteins (metabolism)
  • Chronic Disease
  • Disease Models, Animal
  • Male
  • Metabolic Syndrome (complications, metabolism, pathology, physiopathology)
  • Myocardial Ischemia (complications, metabolism, pathology, physiopathology)
  • Myocardium (metabolism, pathology)
  • Neovascularization, Physiologic
  • Receptors, Notch (metabolism)
  • Signal Transduction
  • Swine
  • Swine, Miniature
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: